Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells

Blood

Volumn 89, Issue 9, 1997, Pages 3345-3353

  Chen, Guo Qiang ^a   Shi, Xue Geng ^a   Tang, Wei ^a   Xiong, Shu Min ^a   Zhu, Jun ^a   Cai, Xun ^a   Man, Ze Guang ^a   Ni, Jian Hua ^a   Shi, Gui Ying ^a   Jia, Pei Ming ^a   Liu, Meng Min ^a   He, Kai Li ^a   Niu, Chao ^a   Ma, Jun ^a   Zhang, Peng ^a   Zhang, Ting Dong ^a   Paul, Pascale ^a   Naoe, Tomoki ^a   Kitamura, Kunio ^a   Miller, Wilson ^a   Waxman, Samuel ^b   Wang, Zhen Yi ^c   De The, Hugues ^a   Chen, Sai Juan ^a   Chen, Zhu ^a   more..

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; PROTEIN BCL 2; RETINOIC ACID; ANTINEOPLASTIC AGENT; DNA; ORGANOARSENIC DERIVATIVE; OXIDE; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; DIAGNOSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ARSENIC POISONING; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL FRACTIONATION; CELL SURVIVAL; DRUG EFFECT; DRUG RESISTANCE; IMMUNOPHENOTYPING; KINETICS; METABOLISM; PATHOLOGY; PHAGOCYTOSIS; PROMYELOCYTIC LEUKEMIA; TIME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENIC POISONING; ARSENICALS; CELL ADHESION; CELL DIVISION; CELL SURVIVAL; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOPHENOTYPING; KINETICS; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; PHAGOCYTOSIS; RECEPTORS, RETINOIC ACID; SUBCELLULAR FRACTIONS; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030610686     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Goddard AD, Borrow J, Freemont P, Solomon E: Characterization of a zinc finger gene disrupted by the 1(15; 17) in acute promyelocytic leukemia. Science 254:1371, 1991
2. Tong JH, Dong S, Geng JP, Huang W, Wang ZY, Sun GL, Chen SJ, Chen Z, Larsen CJ, Berger R: Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants. Oncogene 7:311,1992
3. de The H, Chomienne C, Lanotte M, Degos L, Dejean A: The 1(15; 17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347:558, 1990
4. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD: Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital. Blood 73:1116, 1989
5. Warrell RP Jr, de The H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
6. Kantarjian H, Keating MJ, Walters RS, Smith TL, McCredie KB, Freien EJ: Role of maintenance chemotherapy in acute promyelocytic leukemia. Cancer 59:1258, 1987
7. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
8. Degos L, Dombret H, Chomienne C, Daniel NT, Miclea JM, Chastang C, Castaigne S, Fenaux P: ATRA as a differentiation agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
9. Chen GQ, Shen ZX, Wu F, Man JY, Miao JM, Zhong HJ, Li XS, Zhao JQ, Zhu J, Fang ZW, Chen SJ, Chen Z, Wang ZY: Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia 10:825, 1996
10. Sun GL: The study on post-remission therapies in patients with APL after CR induced by ATRA. Chin J Cancer Res 4:58, 1992
11. Sun GL, OuYang RR, Chen SJ, Gu LJ, Xie WY, Zhang FQ, Li XS, Zhong DH, Cai JR, Chen Z, Wang ZY, Lu JX, Huang LA, Qian ZC, Yu HQ, Wang YL: Treatment of APL with all-trans retinoic acid: A report of five-year experience. Chin J Cancer 11:125, 1993
12. Sun HD, Ma L, Hu XC, Zhang TD: Ai-Lin I treated 32 cases of acute promyelocytic leukemia. Chin J Intégrât Chin West Med 12:170, 1992
13. Huang SL, Guo AX, Xiang Y, Wang XB, Ling HJ, Fu L: Clinical study on the treatment of Acute promyelocytic leukemia mainly with composite Indigo Naturalis tablets. Chin J Hematol 16:26, 1995
14. Zhang P, Wang SY, Hu XH: Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin J Hematol 17:58, 1996
15. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications. Blood 82:2175, 1993
16. Chen GQ, Zhu J, Shi XG, Zhong HJ, Ni JH, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Ma J, Zhang P, Zhang TD, Claude Gazin, Naoe T, Chen SJ, Wang ZY, Chen Z: In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and alteration of PML-RARa/PML protein localization. Blood 88:1052, 1996
17. Jiang C, Lu XX, Garcia G, Thompson HJ: Spontaneous nucleaosomal DNA fragmentation in a mouse leukemic L1210 cell line. Biochem Biophys Res Commun 137:1006, 1986
18. Zhu J, Shi XG, Chu HY, Tong JH, Wang ZY, Naoe T, Waxman S, Chen SJ, Chen Z: Effect of retinoic acid isomers on proliferation, differentiation and PML relocation in the APL cell line NB4. Leukemia 9:302, 1995
19. Mao M, Yu M, Tong JH, Ye J, Zhu J, Huang QH, Fu G, Yu L, Zhao SY, Waxman S, Lanotte M, Wang ZY, Tan JZ, Chen SJ, Chen Z: RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemica cell. Proc Natl Acad Sci USA 93:5910, 1996
20. Weis K, Rambaud S, Lavau C, Jansen JM, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARa in acute promyelocytic leukemia cells. Cell 76:345, 1994
21. Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de Thé H: The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13:1073, 1994
22. Chen Z, Tong JH, Dong S, Zhu J, Wang ZY, Chen S3: Retinoic acod regulatory pathways, chromosomal translocations and acute promyelocytic leukemia. Genes Chromosom Cancer 15:147, 1996
23. Grignani Fr, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pellici PG: The acute promyelocytic leukemia specific PML/RARa protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
24. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T: Accelerated degradation of PMLretinoic acid receptor a (PML-RARA) oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway. Cancer Res 56:2945, 1996
25. Bergamaschi G, Rosti V, Danova M, Lucotti C, Cazzola M: Apoptosis: Biological and clinical aspects. Haematologica 79:86, 1994
26. Ellis RE, Yuan J, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663, 1991
27. Steller H: Mechanisms and genes of cellular suicide. Science 267:1445, 1995
28. Symonds H, Krall L, Remington L, Saenz-Robles M, Löwe S, Jacks T, Dyke T: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703, 1994
29. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
30. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
31. Yang E, Zha JP, Jockei J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric panner for bcl-XL and bcl-2, displaces bax and promotes cell death. Cell 80:285, 1995
32. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel bcl-2-binding protein with anti-cell death activity. Cell 80:279, 1995
33. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activitor of the human bax gene. Cell 80:293, 1995
34. Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53-dependent negative response elemwent in the bcl-2 gene. Cancer Res 53:3331, 1994
35. Sato T, Hanada M, Bodrug S, Irie S, Ivvama N, Boise L, Thompson C, Golemis E, Fong L, Wang HG, Reed JC: Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238, 1994
36. Nielsen FH, Uthus EO: Arsenic, in Frieden E (ed): Biochemistry of the Essential Ultratrace Elements, Plenum, New York, NY, 1981, p 319
37. White K, Tahaoglu E, Steller H: Cell killing by the drosophila gene reaper. Science 271:805, 1996
38. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808, 1996
39. Earnshaw WC: Nuclear changes in apoptosis. Curr Opin Cell Biol 7:337, 1995
40. Kumar S: ICE-like proteases in apoptosis. TIBS 20:198, 1995